[99mTc-DMSA (V)] in detection of metastases of medullary thyroid carcinoma

Iranian Journal of Nuclear Medicine

Volumn 14, Issue 26, 2006, Pages 15-24

  Dabiri, Shahram ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

99mTc DMSA (V) ; Medullary thyroid carcinoma; Metastasis

Indexed keywords

CALCITONIN; CARCINOEMBRYONIC ANTIGEN; SUCCIMER TC 99M; TUMOR MARKER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; FEMALE; GOLD STANDARD; HUMAN; INTERMETHOD COMPARISON; MALE; METASTASIS; SENSITIVITY AND SPECIFICITY; THYROID MEDULLARY CARCINOMA;

EID: 33846796073     PISSN: 16812824     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Favia G, Iacobone M. Medullary thyroid carcinoma: state of the art. G Chir. 2005; Nov-Dec;26(11-12):405-9.
2. Raue F German medullary thyroid carcinoma/multiple endocrine neoplasia registry. German MTC/MEN Study Group. Medullary Thyroid Carcinoma/Multiple Endocrine Neoplasia Type 2. Langenbecks Arch Surg. 1998; 383:334-336.
3. M. Engelbach, R. Gorges, T. Forst, A. Pfützner, R. Dawood, S. Heerdt, T. Kunt, A. Bockisch and J. Beyer. Improved Diagnostic Methods in the Follow-Up of Medullary Thyroid Carcinoma by Highly Specific Calcitonin Measurements. The Journal of Clinical Endocrinology & Metabolism 2000; 85(5): 1890-94.
4. Kameyama K, Takami H. Medullary thyroid carcinoma: nationwide Japanese survey of 634 cases in 1996 and 271 cases in 2002. Endocr J. 2004; Oct; 51(5):453-6.
5. Punales MK, Rocha AP, Gross JL, Maia AL. Medullary thyroid carcinoma: clinical and oncological features and treatment Arq Bras Endocrinol Metabol. 2004 Feb; 48(1):137-46. Epub 2004 Jun 1.
6. Rufini V, Salvatori M, Garganese MC, Di Giuda D, Lodovica Maussier M, Troncone L. Role of nuclear medicine in the diagnosis and therapy of medullary thyroid carcinoma. Rays. 2000 Apr-Jun; 25(2):273-82.
7. Ismailov SI, Piulatova NR. Postoperative calcitonin study in medullary thyroid carcinoma. Endocr Relat Cancer. 2004 Jun; 11(2):357-63.
8. Clarke SEM, MaisY MN, Briton KE, Gildy DL. Tumour imaging in Clinical Nuclear Medicine, 2nd ed. 1991; 434-435.
9. Vierhapper H, Raber W, Bieglmayer C, Kaserer K, Weinhausl A, Niederle B. Routine measurement of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab. 1997; 82:1589-1593.
10. Moley JF, Debenedetti MK, Dilley WG, Tisell LE, Wells SA. Surgical management of patients with persistent or recurrent medullary thyroid cancer. J Intern Med. 1998; 243:521-526.
11. Tisell LE, Dilley WG, Wells Jr SA. Progression of postoperative residual medullary thyroid carcinoma as monitored by plasma calcitonin levels. Surgery. 1996; 119:34-39.
12. Evans DB, Fleming JB, Lee JE, Cote G, Gagel RF. The surgical treatment of medullary thyroid carcinoma. Semin Surg Oncol. 1999; 16:50-63.
13. Gimm O, Ukkat J, Dralle H. Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma. World J Surg. 1998; 22:562-567; discussion 567-568.
14. Kurtaran A, Scheuba C, Kaserer K, Schima W, Czerny C, Angelberger P, Niederle B, Virgolini I. Indium-111-DTPA-D-Phe-1-octreotide and technetium-99m-(V)-dimercaptosuccinic acid scanning in the preoperative staging of medullary thyroid carcinoma. J Nucl Med. 1998 Nov; 39(11):1907-9.
15. 99mTc-DMSA (V)] scintigraphy. Journal of postgraduate medicine. 1995; 41 (1): 12-3.
16. Chow SM, Chan JK, Tiu SC, Choi KL, Tang DL, Law SC. Medullary thyroid carcinoma in Hong Kong Chinese patients. Hong Kong Med J. 2005 Aug; 11(4):251-8.
17. Udelsman R, Ball D, Baylin SB, Wong CY, Osterman FA Jr, Sostre S. Preoperative localization of occult medullary carcinoma of the thyroid gland with single-photon emission tomography dimercaptosuccinic acid. Surgery. 1993 Dec; 114 (6):1083-9.
18. 99mTc(V)-dimercaptosuccinic acid studies in the imaging of recurrent medullary thyroid carcinoma. J Endocrinol. 1995 Feb; 144 (2):339-45.
19. Lebouthillier G, Morais J, Picard M, Picard D, Chartrand R, D'Amour P. Tc-99m sestamibi and other agents in the detection of metastatic medullary carcinoma of the thyroid. Clin Nucl Med. 1993 Aug; 18(8):657-61.
20. Horiuchi K, Yomoda I, Ohta H, Endo K, Yokoyama A. Search for polynuclear pentavalent technetium complex of dimercaptosuccinic acid [Tc(V)-DMS] tumour localization mechanism. I. Medullary thyroid carcinoma animal model. Eur J Nucl Med. 1991; 18(10):796-800.
21. 99mTc-DMSA (V)] in the diagnosis of medullary thyroid carcinoma. Henry Ford Hosp Med J. 1989; 37(3-4):175-7.
22. 99mTc-DMSA (V)] scintigraphy in evaluation of breast mass lesions. Anticancer Res. 1997 May-Jun; 17(3B): 1599-605.
23. 99mTc-DMSA (V)] and TI-201. Clin Nucl Med. 1999 Sep; 24(9):678-83.
24. Mallin WH, Elgazzar AH, Maxon HR 3rd. Imaging modalities in the follow-up of non-iodine avid thyroid carcinoma. Am J Otolaryngol. 1994 Nov-Dec; 15(6):417-22.
25. 99mTc] (v) dimercaptosuccinic acid scintigraphy. Br J Surg. 1989 Dec; 76(12):1278-81.
26. Mojiminiyi OA, Udelsman R, Soper ND, Shepstone BJ, Dudley NE. Pentavalent Tc-99m DMSA scintigraphy. Prospective evaluation of its role in the management of patients with medullary carcinoma of the thyroid. Clin Nucl Med. 1991 Apr; 16(4):259-62.
27. Clarke SE, Lazarus C, Mistry R, Maisey MN. The role of technetium-99m pentavalent DMSA in the management of patients with medullary carcinoma of the thyroid. Br J Radiol. 1987 Nov; 60(719):1089-92.
28. 111In-pentetreotide scintigraphy in the post-thyroidectomy follow-up of patients with medullary thyroid carcinoma. Q J Nucl Med. 1995 Dec; 39(4 Suppl 1):131-3.
29. Adams S, Acker P, Lorenz M, Staib-Sebler E, Hor G. Radioisotope-guided surgery in patients with pheochromocytoma and recurrent medullary thyroid carcinoma: a comparison of preoperative and intraoperative tumor localization with histopathologic findings. Cancer. 2001 Jul 15; 92(2):263-70.
30. Yen TC, King KL, Yang AH, Liu RS, Yeh SH. Comparative radionuclide imaging of metastatic insular carcinoma of the thyroid: value of technetium-99m-(V) DMSA. J Nucl Med. 1996 Jan; 37(1):78-80.
31. 99mTc (V)-dimercapto succinic acid (DMSA) for imaging medullary carcinoma of thyroid and its metastasis. Eur J Nucl Med. 1988; 13(10):507-10.
32. 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid. Eur J Nucl Med. 1996 Oct; 23(10):1367-71.
33. Adams S, Baum RP, Hertel A, Schumm-Draeger PM, Usadel KH, Hor G. Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings. Eur J Nucl Med. 1998 Sep; 25(9):1277-83.
34. 99mTc-tetrofosmin. Nucl Med Commun. 1999 Apr; 20(4):353-9.
35. Arslan N, Ilgan S, Yuksel D, Serdengecti M, Bulakbasi N, Ugur O, Ozguven MA. Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery. Clin Nucl Med. 2001 Aug; 26(8):683-8.
36. Bugalho MJ, Santos JR, Sobrinho L. Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement. J Surg Oncol. 2005 Jul 1; 91(1):56-60.